A Multicenter Phase II, Double-Blind, Placebo-Controlled Trial of Maintenance Ixazomib After Allogeneic Transplantation for High-Risk Multiple Myeloma: Results of the Blood and Marrow Transplant Clinical Trials Network 1302 Trial
一项多中心 II 期、双盲、安慰剂对照试验，评估异基因移植后维持治疗伊沙佐米对高危多发性骨髓瘤的疗效：血液和骨髓移植临床试验网络 1302 试验结果
期刊:Transplantation and Cellular Therapy
影响因子:4.4
doi:10.1016/j.jtct.2022.07.007
Bashir, Qaiser; Nishihori, Taiga; Pasquini, Marcelo C; Martens, Michael J; Wu, Juan; Alsina, Melissa; Anasetti, Claudio; Brunstein, Claudio; Dawson, Peter; Efebera, Yvonne; Gasparetto, Cristina; Geller, Nancy; Giralt, Sergio; Hall, Aric C; Koreth, John; McCarthy, Philip; Scott, Emma; Stadtmauer, Edward A; Vesole, David H; Hari, Parameswaran
